Page last updated: 2024-10-22

alprazolam and Recrudescence

alprazolam has been researched along with Recrudescence in 27 studies

Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.

Research Excerpts

ExcerptRelevanceReference
"Patients with panic disorder plus agoraphobia had 8 weeks of drug treatment (alprazolam or placebo) plus psychological treatment (exposure or relaxation)."9.07Alprazolam and exposure for panic disorder with agoraphobia. Attribution of improvement to medication predicts subsequent relapse. ( Başoğlu, M; Brewin, CR; Kiliç, C; Marks, IM; Swinson, RP, 1994)
"This study was designed to examine the possibility that patients with panic disorder are especially vulnerable to alprazolam withdrawal, as well as to evaluate the efficacy of carbamazepine as adjunctive treatment during alprazolam discontinuation."9.07Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine. ( Colin, V; Klein, E; Lenox, RH; Stolk, J, 1994)
"The authors investigated whether cognitive behavioral treatment could facilitate discontinuation of alprazolam therapy and maintenance of drug abstinence among panic disorder patients treated with alprazolam doses sufficient to suppress spontaneous panic attacks."9.07Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder? ( Bruce, TJ; Gregg, SF; Nuzzarello, A; Spiegel, DA, 1994)
"In a previous paper the authors reported survival data for 20 panic disorder patients whose therapeutic doses of alprazolam were tapered by one of two methods: slow, flexible drug taper with supportive medical management or the same taper procedure carried out concurrently with cognitive behavior therapy."7.69Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder. ( Bruce, TJ; Gregg, SF; Nuzzarello, A; Spiegel, DA, 1995)
"This is a case report of severe psychosis and seizures following abrupt discontinuation of alprazolam and then the recurrence of seizures at the end of a gradual tapering schedule."7.68Death following suspected alprazolam withdrawal seizures: a case report. ( Bryant, SG; Haque, W; Watson, DJ, 1990)
"Panic disorder is a chronic illness with only some degree of spontaneous recovery."6.67Discontinuation reactions to alprazolam in panic disorder. ( Pecknold, JC, 1993)
"Patients with panic disorder plus agoraphobia had 8 weeks of drug treatment (alprazolam or placebo) plus psychological treatment (exposure or relaxation)."5.07Alprazolam and exposure for panic disorder with agoraphobia. Attribution of improvement to medication predicts subsequent relapse. ( Başoğlu, M; Brewin, CR; Kiliç, C; Marks, IM; Swinson, RP, 1994)
"This study was designed to examine the possibility that patients with panic disorder are especially vulnerable to alprazolam withdrawal, as well as to evaluate the efficacy of carbamazepine as adjunctive treatment during alprazolam discontinuation."5.07Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine. ( Colin, V; Klein, E; Lenox, RH; Stolk, J, 1994)
" The present study provided systematic data from a double blind comparison of maintenance therapy (up to 8 months) of panic disorder with or without agoraphobia with alprazolam, imipramine, or placebo in 181 patients who had responded to the same regimen in a randomized 8-week treatment trial."5.07Maintenance drug therapy of panic disorder. ( Ayuso, JL; Cassano, GB; Curtis, GC; Massana, J; Perugi, G; Udina, C, 1993)
"The authors investigated whether cognitive behavioral treatment could facilitate discontinuation of alprazolam therapy and maintenance of drug abstinence among panic disorder patients treated with alprazolam doses sufficient to suppress spontaneous panic attacks."5.07Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder? ( Bruce, TJ; Gregg, SF; Nuzzarello, A; Spiegel, DA, 1994)
"Forty-eight patients with panic disorder completing 8 months of maintenance treatment with alprazolam (mean dose, 5."5.07Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper. ( Rickels, K; Schweizer, E; Weiss, S; Zavodnick, S, 1993)
"In a previous paper the authors reported survival data for 20 panic disorder patients whose therapeutic doses of alprazolam were tapered by one of two methods: slow, flexible drug taper with supportive medical management or the same taper procedure carried out concurrently with cognitive behavior therapy."3.69Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder. ( Bruce, TJ; Gregg, SF; Nuzzarello, A; Spiegel, DA, 1995)
"This is a case report of severe psychosis and seizures following abrupt discontinuation of alprazolam and then the recurrence of seizures at the end of a gradual tapering schedule."3.68Death following suspected alprazolam withdrawal seizures: a case report. ( Bryant, SG; Haque, W; Watson, DJ, 1990)
"Panic disorder is a chronic illness with only some degree of spontaneous recovery."2.67Discontinuation reactions to alprazolam in panic disorder. ( Pecknold, JC, 1993)
"Rebound anxiety and withdrawal symptoms were identified in a substantial minority of patients."2.67Controlled discontinuation of benzodiazepine treatment for patients with panic disorder. ( Cook, B; Garvey, MJ; Noyes, R; Suelzer, M, 1991)
"No serious or life-threatening withdrawal symptoms were reported, but distinct, transient, mild to moderate withdrawal syndrome occurred in 35% of the alprazolam-treated group and in none of the placebo-treated group."2.66Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects. ( Kuch, K; Lewis, CP; Pecknold, JC; Swinson, RP, 1988)
" Finally, the authors discuss general issues concerning the relapse of patients upon drug discontinuation, the long-term use of benzodiazepines, and other important issues concerning the use of these agents for the treatment of social phobia."2.39Treatment of social phobia with benzodiazepines. ( Davidson, JR; Potts, NL; Tupler, LA, 1994)
"Alprazolam treatment was tapered in 17 panic patients at a rate of 10% of the starting dose every 3 days."1.27Discontinuation of alprazolam treatment in panic patients. ( Campeas, R; Davies, SO; Fyer, AJ; Goetz, D; Gorman, JM; Klein, DF; Levin, A; Liebowitz, MR, 1987)

Research

Studies (27)

TimeframeStudies, this research(%)All Research%
pre-19905 (18.52)18.7374
1990's16 (59.26)18.2507
2000's4 (14.81)29.6817
2010's2 (7.41)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nivy, R1
Segev, G1
Rimer, D1
Bruchim, Y1
Aroch, I1
Mazaki-Tovi, M1
Dueñas-Laita, A1
Ruiz-Muñoz, P1
Armentia, A1
Pinacho, F1
Martín-Armentia, B1
Roberson-Nay, R1
Latendresse, SJ1
Kendler, KS1
Klein, E2
Andersch, S1
Hetta, J1
Uhlenhuth, EH1
Leon, AC1
Matuzas, W1
Chouinard, G1
Labonte, A1
Fontaine, R1
Annable, L1
Bruce, TJ2
Spiegel, DA2
Gregg, SF2
Nuzzarello, A2
Romach, M1
Busto, U1
Somer, G1
Kaplan, HL1
Sellers, E1
Başoğlu, M1
Marks, IM1
Kiliç, C1
Brewin, CR1
Swinson, RP2
Colin, V1
Stolk, J1
Lenox, RH1
Davidson, JR1
Tupler, LA1
Potts, NL1
Curtis, GC1
Massana, J1
Udina, C1
Ayuso, JL1
Cassano, GB1
Perugi, G1
Pecknold, JC2
Ballenger, JC1
Pecknold, J1
Rickels, K2
Sellers, EM1
Schweizer, E1
Weiss, S1
Zavodnick, S1
Fava, GA1
Rosenbaum, JF1
Pollack, MH1
Pollock, RA1
McCann, UD1
Ricaurte, GA1
Ross, CA1
Noyes, R1
Garvey, MJ1
Cook, B1
Suelzer, M1
Haque, W1
Watson, DJ1
Bryant, SG1
Roy-Byrne, PP1
Dager, SR1
Cowley, DS1
Vitaliano, P1
Dunner, DL1
Fyer, AJ2
Liebowitz, MR2
Gorman, JM2
Campeas, R2
Levin, A2
Sandberg, D1
Fyer, M1
Hollander, E1
Papp, L1
Goetz, D2
Kuch, K1
Lewis, CP1
Davies, SO1
Klein, DF1

Reviews

3 reviews available for alprazolam and Recrudescence

ArticleYear
Treatment of social phobia with benzodiazepines.
    The Journal of clinical psychiatry, 1994, Volume: 55 Suppl

    Topics: Alprazolam; Benzodiazepines; Clinical Trials as Topic; Clonazepam; Double-Blind Method; Humans; Phob

1994
Medication discontinuation in panic disorder.
    The Journal of clinical psychiatry, 1993, Volume: 54 Suppl

    Topics: Alprazolam; Benzodiazepines; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Admini

1993
Clinical issues in the long-term treatment of panic disorder.
    The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 10

    Topics: Age Factors; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Child; Cognitive B

1996

Trials

14 trials available for alprazolam and Recrudescence

ArticleYear
A prospective randomized study of efficacy of 2 treatment protocols in preventing recurrence of clinical signs in 51 male cats with obstructive idiopathic cystitis.
    Journal of veterinary internal medicine, 2019, Volume: 33, Issue:5

    Topics: Adrenergic alpha-Antagonists; Alprazolam; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cat Dise

2019
Successful treatment of chronic drug-resistant urticaria with alprazolam.
    The Journal of allergy and clinical immunology, 2009, Volume: 123, Issue:2

    Topics: Alprazolam; Chronic Disease; Cyproheptadine; Humans; Platelet Membrane Glycoproteins; Receptors, G-P

2009
A 15-year follow-up study of patients with panic disorder.
    European psychiatry : the journal of the Association of European Psychiatrists, 2003, Volume: 18, Issue:8

    Topics: Activities of Daily Living; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Sec

2003
Psychopathology of panic attacks in panic disorder.
    Journal of affective disorders, 2006, Volume: 92, Issue:1

    Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Cognition; Humans; I

2006
New concepts in benzodiazepine therapy: rebound anxiety and new indications for the more potent benzodiazepines.
    Progress in neuro-psychopharmacology & biological psychiatry, 1983, Volume: 7, Issue:4-6

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Bromazepam; C

1983
Alprazolam and exposure for panic disorder with agoraphobia. Attribution of improvement to medication predicts subsequent relapse.
    The British journal of psychiatry : the journal of mental science, 1994, Volume: 164, Issue:5

    Topics: Adult; Agoraphobia; Alprazolam; Arousal; Combined Modality Therapy; Desensitization, Psychologic; Fe

1994
Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.
    The American journal of psychiatry, 1994, Volume: 151, Issue:12

    Topics: Adult; Alprazolam; Anxiety Disorders; Carbamazepine; Double-Blind Method; Drug Administration Schedu

1994
Maintenance drug therapy of panic disorder.
    Journal of psychiatric research, 1993, Volume: 27 Suppl 1

    Topics: Agoraphobia; Alprazolam; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Imipramine;

1993
Discontinuation reactions to alprazolam in panic disorder.
    Journal of psychiatric research, 1993, Volume: 27 Suppl 1

    Topics: Agoraphobia; Alprazolam; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Adminis

1993
Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder?
    The American journal of psychiatry, 1994, Volume: 151, Issue:6

    Topics: Adult; Alprazolam; Ambulatory Care; Cognitive Behavioral Therapy; Combined Modality Therapy; Drug Ad

1994
Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper.
    Archives of general psychiatry, 1993, Volume: 50, Issue:1

    Topics: Adult; Alprazolam; Ambulatory Care; Dose-Response Relationship, Drug; Double-Blind Method; Drug Admi

1993
Controlled discontinuation of benzodiazepine treatment for patients with panic disorder.
    The American journal of psychiatry, 1991, Volume: 148, Issue:4

    Topics: Adult; Alprazolam; Anxiety Disorders; Diazepam; Double-Blind Method; Female; Half-Life; Humans; Male

1991
Relapse and rebound following discontinuation of benzodiazepine treatment of panic attacks: alprazolam versus diazepam.
    The American journal of psychiatry, 1989, Volume: 146, Issue:7

    Topics: Adult; Alprazolam; Anxiety; Diazepam; Double-Blind Method; Fear; Female; Humans; Male; Middle Aged;

1989
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
    Archives of general psychiatry, 1988, Volume: 45, Issue:5

    Topics: Adult; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Drug Administration Schedule; Fear;

1988

Other Studies

10 other studies available for alprazolam and Recrudescence

ArticleYear
A latent class approach to the external validation of respiratory and non-respiratory panic subtypes.
    Psychological medicine, 2012, Volume: 42, Issue:3

    Topics: Age of Onset; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Diagnostic and Statistical Man

2012
The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
    The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 14

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Delay

2002
Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder.
    The American journal of psychiatry, 1995, Volume: 152, Issue:8

    Topics: Adult; Alprazolam; Cognitive Behavioral Therapy; Combined Modality Therapy; Drug Administration Sche

1995
Clinical aspects of chronic use of alprazolam and lorazepam.
    The American journal of psychiatry, 1995, Volume: 152, Issue:8

    Topics: Alprazolam; Ambulatory Care; Anxiety Disorders; Depressive Disorder; Drug Administration Schedule; F

1995
Anxiety sensitivity.
    The American journal of psychiatry, 1996, Volume: 153, Issue:8

    Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Cognitive Behavioral Therapy; Combined

1996
MDMA ("ecstasy") and panic disorder: induction by a single dose.
    Biological psychiatry, 1992, Nov-15, Volume: 32, Issue:10

    Topics: 3,4-Methylenedioxyamphetamine; Administration, Oral; Adult; Alprazolam; Anxiety Disorders; Arousal;

1992
Adverse reaction to generic alprazolam.
    The American journal of psychiatry, 1991, Volume: 148, Issue:11

    Topics: Alprazolam; Drugs, Generic; Female; Humans; Middle Aged; Panic Disorder; Recurrence

1991
Death following suspected alprazolam withdrawal seizures: a case report.
    Texas medicine, 1990, Volume: 86, Issue:1

    Topics: Alprazolam; Arrhythmias, Cardiac; Death, Sudden; Female; Humans; Middle Aged; Psychoses, Substance-I

1990
Effects of clonidine on alprazolam discontinuation in panic patients: a pilot study.
    Journal of clinical psychopharmacology, 1988, Volume: 8, Issue:4

    Topics: Adult; Alprazolam; Clonidine; Female; Humans; Male; Phobic Disorders; Prospective Studies; Psychiatr

1988
Discontinuation of alprazolam treatment in panic patients.
    The American journal of psychiatry, 1987, Volume: 144, Issue:3

    Topics: Acute Disease; Adult; Alprazolam; Anxiety Disorders; Dizziness; Fear; Female; Humans; Male; Middle A

1987